148 related articles for article (PubMed ID: 16708557)
1. [The influence of IL-6 polymorphism on efficacy of treatment of rheumatoid arthritis patients with methotrexate and prednisone].
Pawlik A; Czerny B; Dabrowska-Zamojcin E; Górnik W; Poziomkowska I; Gawrońska-Szklarz B; Herczyńska M
Pol Arch Med Wewn; 2005 Sep; 114(3):843-7. PubMed ID: 16708557
[TBL] [Abstract][Full Text] [Related]
2. IL-6 promoter polymorphism in patients with rheumatoid arthritis.
Pawlik A; Wrzesniewska J; Florczak M; Gawronska-Szklarz B; Herczynska M
Scand J Rheumatol; 2005; 34(2):109-13. PubMed ID: 16095005
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis.
Palomino-Morales R; Gonzalez-Juanatey C; Vazquez-Rodriguez TR; Miranda-Filloy JA; Llorca J; Martin J; Gonzalez-Gay MA
Clin Exp Rheumatol; 2009; 27(6):964-70. PubMed ID: 20149313
[TBL] [Abstract][Full Text] [Related]
4. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R
Ann Rheum Dis; 2015 Jan; 74(1):27-34. PubMed ID: 25359382
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis.
Fabris M; Tolusso B; Di Poi E; Assaloni R; Sinigaglia L; Ferraccioli G
J Rheumatol; 2002 Sep; 29(9):1847-50. PubMed ID: 12233877
[TBL] [Abstract][Full Text] [Related]
7. IL1beta+3953 exon 5 and IL-2 -330 promoter polymorphisms in patients with rheumatoid arthritis.
Pawlik A; Kurzawski M; Florczak M; Gawronska Szklarz B; Herczyńska M
Clin Exp Rheumatol; 2005; 23(2):159-64. PubMed ID: 15895884
[TBL] [Abstract][Full Text] [Related]
8. The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis.
Pawlik A; Wrzesniewska J; Florczak M; Gawronska-Szklarz B; Herczynska M
Rheumatol Int; 2005 Nov; 26(1):48-51. PubMed ID: 15660235
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-18 gene (IL18) promoter polymorphisms in patients with rheumatoid arthritis.
Pawlik A; Kurzawski M; Drozdzik M; Dziedziejko V; Safranow K; Herczynska M
Scand J Rheumatol; 2009; 38(3):159-65. PubMed ID: 19229765
[TBL] [Abstract][Full Text] [Related]
10. PTPN22 1858C>T polymorphism is strongly associated with rheumatoid arthritis but not with a response to methotrexate therapy.
Majorczyk E; Pawlik A; Kuśnierczyk P
Int Immunopharmacol; 2010 Dec; 10(12):1626-9. PubMed ID: 20888443
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 10 and tumor necrosis factor-alpha genotypes in rheumatoid arthritis--association with clinical response to glucocorticoids.
de Paz B; Alperi-López M; Ballina-García FJ; Prado C; Mozo L; Gutiérrez C; Suárez A
J Rheumatol; 2010 Mar; 37(3):503-11. PubMed ID: 20080912
[TBL] [Abstract][Full Text] [Related]
12. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.
Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Breedveld FC; Dijkmans BA;
Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-77-82. PubMed ID: 17083767
[TBL] [Abstract][Full Text] [Related]
13. Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study).
Wevers-de Boer K; Visser K; Heimans L; Ronday HK; Molenaar E; Groenendael JH; Peeters AJ; Westedt ML; Collée G; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
Ann Rheum Dis; 2012 Sep; 71(9):1472-7. PubMed ID: 22402145
[TBL] [Abstract][Full Text] [Related]
14. The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis.
Fabris M; Quartuccio L; Lombardi S; Saracco M; Atzeni F; Carletto A; Cimmino M; Fabro C; Pontarini E; Pellerito R; Bambara LM; Sarzi-Puttini P; Cutolo M; Manfredi M; Benucci M; Morassi P; Fischetti F; Padovan M; Govoni M; Curcio F; Tonutti E; De Vita S
Autoimmun Rev; 2012 Mar; 11(5):315-20. PubMed ID: 20974296
[TBL] [Abstract][Full Text] [Related]
15. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis.
Pawlik A; Kurzawski M; Szklarz BG; Herczynska M; Drozdzik M
Clin Rheumatol; 2005 Sep; 24(5):480-4. PubMed ID: 15915323
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids in the treatment of rheumatoid arthritis: still used after 65 years.
Bijlsma JW; Jacobs JW
Ann N Y Acad Sci; 2014 May; 1318():27-31. PubMed ID: 24641732
[TBL] [Abstract][Full Text] [Related]
18. The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs.
Drozdzik M; Rudas T; Pawlik A; Kurzawski M; Czerny B; Gornik W; Herczynska M
Eur J Clin Pharmacol; 2006 Nov; 62(11):933-7. PubMed ID: 16932953
[TBL] [Abstract][Full Text] [Related]
19. Influence of interleukin-4 gene polymorphisms and interleukin-4 serum level on susceptibility and severity of rheumatoid arthritis in Egyptian population.
Hussein YM; El-Shal AS; Rezk NA; Abdel Galil SM; Alzahrani SS
Cytokine; 2013 Mar; 61(3):849-55. PubMed ID: 23394902
[TBL] [Abstract][Full Text] [Related]
20. IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy.
Tolusso B; Pietrapertosa D; Morelli A; De Santis M; Gremese E; Farina G; Carniello SG; Del Frate M; Ferraccioli G
Pharmacogenomics; 2006 Jul; 7(5):683-95. PubMed ID: 16886894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
